Avestar Capital, LLC Biogen Inc. Call Options Transaction History

Avestar Capital, LLC

  • $943 Million
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 01, 2022
SELL
$223.92 - $287.77 $1.01 Million - $1.29 Million
-4,500 Reduced 69.23%
2,000 $480,000
Q3 2021

Nov 09, 2021
BUY
$282.99 - $369.05 $848,970 - $1.11 Million
3,000 Added 85.71%
6,500 $1.84 Million
Q2 2021

Aug 03, 2021
BUY
$259.0 - $414.71 $906,500 - $1.45 Million
3,500 New
3,500 $1.21 Million

Others Institutions Holding BIIB

# of Institutions
1,047
Shares Held
126M
Call Options Held
1.37M
Put Options Held
1.35M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Avestar Capital, LLC Portfolio

Follow Avestar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email